Xanthan Gum

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: digestion weight heart

Research Overview

Recent research on xanthan gum (XG) is dominated by studies linking its molecular structure and solution behavior to functional performance in complex formulations. The most studied areas include (i) fundamental physicochemical and rheological properties in aqueous media—especially how pH, ionic strength, temperature, shear, and additives drive helix–coil transitions and macromolecular association—and (ii) formulation science in foods and biomedicine, where XG is compared with other biopolymers (e.g., alginate, pectin, chitosan, gum Arabic) for encapsulation and controlled-release applications. A substantial applied literature also examines XG in mixed biopolymer systems (e.g., with proteins, konjac glucomannan, carrageenan, agar) to tune gelation, water-holding capacity, thermal stability, and shear-thinning behavior, as well as in structured lipid systems (oleogels) and emulsions designed to protect oxidation-sensitive or poorly bioaccessible lipophilic compounds.

The strongest evidence supports XG as a robust, versatile rheology modifier and stabilizer whose performance can be predictably tuned through formulation variables and biopolymer interactions. Across multiple application contexts, XG consistently contributes to shear-thinning viscosity, improved network formation (via hydrogen bonding and other intermolecular interactions), and enhanced stability of dispersed systems. In delivery-oriented food matrices, XG-containing systems (e.g., protein/XG Pickering HIPEs and WPI/XG foam-templated oleogels) show strong evidence for improving retention and stability of encapsulated bioactives under stressors (heat, pro-oxidants) and for increasing in vitro bioaccessibility relative to non-structured oil phases. In parallel, reviews of drug delivery highlight XG’s attractiveness as a natural, hydrophilic, biocompatible polymer with chemical modifiability and utility across payload classes (small molecules to biomacromolecules), reinforcing its role as a broadly enabling excipient rather than a narrowly targeted active material.

Key gaps remain in translating formulation-level benefits into standardized, scalable, and application-specific performance. More research is needed to (i) establish clearer structure–function relationships that connect XG molecular weight distribution, substitution patterns (acetyl/pyruvate), and processing history to macroscopic outcomes; (ii) optimize processing methods that mitigate practical limitations such as high viscosity and long hydration time (e.g., ultrasound modification) while preserving desired functionality and ensuring batch-to-batch reproducibility; and (iii) expand rigorous in vivo and real-world validation for delivery claims, including long-term stability, sensory impacts (e.g., flavor masking), and safety/efficacy endpoints. Emerging directions—such as encapsulation for agricultural plant probiotics—also require field-scale studies on release kinetics in soils, interactions with native microbiomes, and environmental fate to substantiate performance beyond proof-of-concept formulations.

1. What conditions has Xanthan Gum been studied for?

  • Improving delivery/bioavailability of nutrients and bioactives (functional food/supplement context): Studied as part of encapsulation and structured delivery systems (e.g., nanoencapsulation, Pickering emulsions/HIPEs, oleogels) to protect compounds and improve stability and release.

  • Oxidation-sensitive lipid products and carotenoids: Studied in delivery vehicles for Antarctic krill oil to improve oxidative stability and increase astaxanthin bioaccessibility.

  • Hydrophobic polyphenols: Studied for encapsulating quercetin in a pecan protein/xanthan gum Pickering high internal phase emulsion to improve retention under stressors and improve in vitro digestion bioaccessibility.

  • Oropharyngeal dysphagia (OD): Mentioned in the context of thickened fluids as a therapeutic strategy; the abstract provided refers to a mixed gum/starch thickener and α-amylase resistance (xanthan gum is a common gum in such systems, but the excerpt does not explicitly confirm xanthan as the gum used).

  • Drug delivery (broad biomedical applications): Reviewed as a natural polymer for controlled/sustained delivery of drugs, genetic materials, proteins, and peptides.

  • Topical controlled delivery: Studied as a modifier of an olive oil nanoemulsion (with gum acacia) to increase viscosity, improve encapsulation efficiency, and slow drug release.

  • Agricultural/soil health applications (not human clinical conditions): Studied for microencapsulation/controlled release of plant probiotic bacteria and as xanthan gum–cellulose fiber hydrogels to improve soil water retention and plant growth.

  • Food texture and stability challenges: Studied for freeze-thaw stability of frozen foods and emulsions; also for tuning gel properties in mixed polysaccharide gels.

  • Nanomaterials synthesis (non-therapeutic): Studied as a reducing/stabilizing agent for gold nanoparticle synthesis.

2. Does it work in treating those conditions? Summarize the evidence.

  • Direct treatment evidence in humans: The provided abstracts do not include human clinical trial outcomes showing xanthan gum alone treats a disease. Most evidence here is formulation/technology-focused (delivery systems, stability, rheology) or non-human (agriculture/soil).

  • Bioaccessibility improvements (in vitro digestion models): In a whey protein isolate (WPI) + xanthan gum foam-templated oleogel for Antarctic krill oil, the oleogel showed superior oxidative stability versus krill oil and considerably higher astaxanthin bioaccessibility in in vitro digestion. This supports a plausible benefit for nutrient delivery, but it is not the same as demonstrating clinical benefit in humans.

  • Protection/retention of bioactives under stress (lab stress tests): A pecan protein/xanthan gum Pickering HIPE used to encapsulate quercetin showed high retention and improved gel strength; the interface film contributed to retention when exposed to heat, iron ions, and hydrogen peroxide. It also improved quercetin bioaccessibility after in vitro simulated digestion compared with quercetin in oil.

  • Controlled drug release (formulation evidence): In an olive oil nanoemulsion, modification with xanthan gum (and gum acacia) increased viscosity and achieved high encapsulation efficiency (>85%) and controlled drug release (reported as “up to 40%” release, with Korsmeyer–Peppas kinetics). This supports xanthan gum’s role in controlled delivery, but does not establish clinical efficacy for any specific disease.

  • Dysphagia thickening (therapeutic strategy context): The dysphagia abstract excerpt indicates thickened fluids are used therapeutically and evaluates α-amylase resistance of a mixed gum/starch thickener, but the excerpt does not provide outcome data or explicitly isolate xanthan gum’s effect.

Overall, within these abstracts, xanthan gum “works” most clearly as a functional excipient (stabilizer, thickener, encapsulation polymer) that can improve stability, retention, and in vitro bioaccessibility of actives—rather than as a standalone therapeutic agent proven to treat a medical condition.

3. What health benefits does it have?

  • May improve stability and delivery of bioactives in foods/supplements: The encapsulation review highlights polymers including xanthan gum as tools to improve system stability, control release rates, maintain bioactivity under extreme conditions, and reduce lipid oxidation—all relevant to functional foods and supplements.

  • May increase bioaccessibility of certain compounds (preclinical/in vitro evidence):

    • Quercetin: PP/XG Pickering HIPE improved bioaccessibility after in vitro simulated digestion compared with quercetin in oil.

    • Astaxanthin (in krill oil): WPI/XG oleogels showed considerably higher bioaccessibility in in vitro digestion than krill oil.

  • May reduce oxidation of sensitive lipids (product-level benefit): The krill oil oleogel study reported superior oxidative stability versus krill oil, which could help preserve quality and potentially preserve bioactive content.

  • Potential supportive role in dysphagia management (indirect): Thickened fluids are a therapeutic strategy for oropharyngeal dysphagia; xanthan gum is widely used as a thickener in industry, but the provided excerpt does not allow attributing clinical benefit specifically to xanthan gum.

Important limitation: these abstracts primarily support benefits related to formulation performance (stability, controlled release, bioaccessibility in models). They do not establish that xanthan gum supplementation itself produces specific clinical health outcomes.

4. Does it have any downsides or side effects?

  • Practical/formulation downsides noted: One abstract states xanthan gum can improve freeze-thaw stability of frozen foods, but its high viscosity and long hydration time limit its application. Ultrasound was explored to reduce viscosity. This is a usability/manufacturing limitation rather than a human side effect, but it can affect tolerability/texture in consumer products.

  • Potential digestive tolerance not addressed in these abstracts: None of the provided abstracts report gastrointestinal side effects, intolerance, or adverse events in humans. (In general practice, gums can cause GI symptoms in some people depending on dose and individual sensitivity, but that is not evidenced in the provided text.)

  • Context-specific risks not evaluated here: Encapsulation and nanoemulsion systems can change absorption and exposure of actives; however, the abstracts provided do not present safety outcomes for these systems in humans.

Bottom line from the provided evidence: the main “downsides” documented here are high viscosity and slow hydration (technical limitations). Human adverse effects are not characterized in these abstracts.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

No pharmacogenomic findings are described in the provided abstracts. They do not report gene–xanthan gum interactions, genotype-stratified responses, or genetic predictors of benefit/harm. Based on these sources alone, there is insufficient evidence to claim xanthan gum is beneficial or harmful for any specific genetic variation.

References

  1. Bioactive compound encapsulation: Characteristics, applications in food systems, and implications for human health.
    Alieh Rezagholizade-Shirvan, Mahya Soltani, Samira Shokri, Ramin Radfar, Masoumeh Arab, Ehsan Shamloo (2024) - Food chemistry: X
  2. Xanthan gum in aqueous solutions: Fundamentals and applications.
    Emmanuel M Nsengiyumva, Paschalis Alexandridis (2022) - International journal of biological macromolecules
  3. Advances in Xanthan Gum-Based Systems for the Delivery of Therapeutic Agents.
    Mahima Jadav, Deep Pooja, David J Adams, Hitesh Kulhari (2023) - Pharmaceutics
  4. Fabrication of pickering high internal phase emulsions stabilized by pecan protein/xanthan gum for enhanced stability and bioaccessibility of quercetin.
    Meigui Huang, Yu Wang, Mehraj Ahmad, Ruifeng Ying, Yaosong Wang, Chen Tan (2021) - Food chemistry
  5. Structural, mechanical, barrier and antioxidant properties of pectin and xanthan gum edible films loaded with grapefruit essential oil.
    Saurabh Bhatia, Ahmed Al-Harrasi, Yasir Abbas Shah, Aaisha Naseer Saif Alrasbi, Muhammad Jawad, Esra Koca, Levent Yurdaer Aydemir, Jawaher Abdullah Alamoudi, Yosif Almoshari, Syam Mohan (2024) - Heliyon
  6. Foam-templated oleogels constructed by whey protein isolate and xanthan gum: Multiple-effect delivery vehicle for Antarctic krill oil.
    Wanjun Zhao, Zihao Wei, Changhu Xue (2024) - International journal of biological macromolecules
  7. Effect and characterization of konjac glucomannan on xanthan gum/κ-carrageenan/agar system.
    Yicun Lin, Ling Zhang, Xinxin Li, Chuang Zhai, Jiaming Liu, Ran Zhang (2024) - International journal of biological macromolecules
  8. Structural, rheological and functional properties of ultrasonic treated xanthan gums.
    Ji Kang, Hongxia Yue, Xinxue Li, Chao He, Qin Li, Liting Cheng, Jixiang Zhang, Yan Liu, Shujun Wang, Qingbin Guo (2023) - International journal of biological macromolecules
  9. Advancements in xanthan gum: A macromolecule for encapsulating plant probiotic bacteria with enhanced properties.
    Mohadeseh Hassanisaadi, Masoumeh Vatankhah, John F Kennedy, Ali Rabiei, Roohallah Saberi Riseh (2025) - Carbohydrate polymers
  10. Development of a Xanthan Gum Based Superabsorbent and Water Retaining Composites for Agricultural and Forestry Applications.
    Alessandro Sorze, Francesco Valentini, Andrea Dorigato, Alessandro Pegoretti (2023) - Molecules (Basel, Switzerland)
  11. Therapeutic Effect, Rheological Properties and α-Amylase Resistance of a New Mixed Starch and Xanthan Gum Thickener on Four Different Phenotypes of Patients with Oropharyngeal Dysphagia.
    Omar Ortega, Mireia Bolívar-Prados, Viridiana Arreola, Weslania Viviane Nascimento, Noemí Tomsen, Crispulo Gallegos, Edmundo Brito-de La Fuente, Pere Clavé (2020) - Nutrients
  12. Xanthan and gum acacia modified olive oil based nanoemulsion as a controlled delivery vehicle for topical formulations.
    Khadijatul Kobra, Siew Yee Wong, Mohammad A Jafar Mazumder, Xu Li, M Tarik Arafat (2023) - International journal of biological macromolecules
  13. Pickering emulsion with high freeze-thaw stability stabilized by xanthan gum/lysozyme nanoparticles and konjac glucomannan.
    Wei Xu, Yin Jia, Jingyi Li, Haomin Sun, Liwen Cai, Guanchen Wu, Mengyao Kang, Jiaxiang Zang, Denglin Luo (2024) - International journal of biological macromolecules
  14. Xanthan gum stabilized gold nanoparticles: characterization, biocompatibility, stability and cytotoxicity.
    Deep Pooja, Sravani Panyaram, Hitesh Kulhari, Shyam S Rachamalla, Ramakrishna Sistla (2014) - Carbohydrate polymers
  15. The Effect of Ionic Strength on the Formation and Stability of Ovalbumin-Xanthan Gum Complex Emulsions.
    Yuanxue Gao, Wen He, Yan Zhao, Yao Yao, Shuping Chen, Lilan Xu, Na Wu, Yonggang Tu (2024) - Foods (Basel, Switzerland)
  16. Effect of hydrothermal treatment on the rheological properties of xanthan gum.
    Zhi-Xuan Li, Hui-Qiong Deng, Jie Jiang, Zi-Qing He, Dong-Mei Li, Xi-Guang Ye, Yun Chen, Yong Hu, Chao Huang (2024) - International journal of biological macromolecules
  17. Chitosan coated alginate-xanthan gum bead enhanced pH and thermotolerance of Lactobacillus plantarum LAB12.
    Ismail M Fareez, Siong Meng Lim, Rakesh K Mishra, Kalavathy Ramasamy (2015) - International journal of biological macromolecules
  18. Selective adsorption and separation of methylene blue by facily preparable xanthan gum/amantadine composites.
    Yan Li, Ziqian Liu, Xin Wan, Lingying Xie, Hui Chen, Guo Qu, Han Zhang, Yue-Fei Zhang, Shicheng Zhao (2023) - International journal of biological macromolecules
  19. Enhancing Gluten-Free Bread Production: Impact of Hydroxypropyl Methylcellulose, Psyllium Husk Fiber, and Xanthan Gum on Dough Characteristics and Bread Quality.
    Ramón Torres-Pérez, Elena Martínez-García, Marta Maravilla Siguero-Tudela, Purificación García-Segovia, Javier Martínez-Monzó, Marta Igual (2024) - Foods (Basel, Switzerland)
  20. Characterization and Antioxidant Activity of a Low-Molecular-Weight Xanthan Gum.
    Xiaolong Hu, Kangli Wang, Miao Yu, Peixin He, Hanzhen Qiao, Huiru Zhang, Zichao Wang (2019) - Biomolecules


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!